Cash flow Statement (Quarterly, GAAP
in millions $) |
(Mar 31 2020) 3 Months |
(Dec 31 2019) 12 Months |
(Sep 30 2019) 9 Months |
(Jun 30 2019) 6 Months |
(Mar 31 2019) 3 Months |
Income |
-0.12 |
-0.04 |
-0.21 |
-0.08 |
-0.04 |
Depreciation & amortization |
- |
- |
- |
- |
- |
Amortization of Other Assets |
- |
- |
- |
- |
- |
Increase (Decrease) in Deferred Revenue
|
- |
- |
- |
- |
- |
Restructuring & Impairment Charges |
- |
- |
- |
- |
- |
Provision for Doubtful Accounts |
- |
- |
- |
- |
- |
Increase (Decrease) in Inventories |
- |
- |
- |
- |
- |
R & D, Environmental and Other Expense |
- |
- |
- |
- |
- |
Gain (Loss) on Disposition of Assets |
- |
- |
- |
- |
- |
Employee Benefits and Share-based Compensation |
- |
- |
- |
- |
- |
Income (Loss) from Equity Method Investments |
- |
- |
- |
- |
- |
Financial Instruments and Foreign Currency Transaction |
- |
- |
- |
- |
- |
Shares Isssed To Vivicells |
- |
- |
- |
- |
- |
Shares Issued As Payment Of Notes |
- |
- |
- |
- |
- |
Payment For Acquisition Of Biocordcell |
- |
- |
- |
- |
- |
Change In Value Of Contingent Consideration |
- |
- |
- |
- |
- |
Interest Forgiven On Notes Payable |
- |
- |
- |
- |
- |
Consolidated Net Loss |
- |
- |
- |
- |
- |
Incomeloss From Discontinued Operations |
- |
- |
- |
- |
- |
Noncash Interest Expense On Ironridge Global Transaction |
- |
- |
- |
- |
- |
Impairment Of Vidaplus And Loan Receivable |
- |
- |
- |
- |
- |
Acquisition Of Neocells Customer Contracts As Repayment |
- |
- |
- |
- |
- |
Loans And Leases Receivable Gain Loss On Sales Net |
- |
- |
- |
- |
- |
Increase Decrease In Severance Payable |
- |
-0.03 |
-0.03 |
-0.03 |
-0.12 |
Cash And Cash Equivalents Period Increase Decrease Continuing Operations |
-0.52 |
- |
- |
- |
- |
Income taxes |
- |
- |
- |
- |
- |
Unrealized Gain (Loss) on Derivatives |
- |
- |
- |
- |
- |
Accounts Receivable |
0.01 |
-0.77 |
-0.03 |
-0.01 |
0.00 |
Increase (Decrease) in Accounts Payable |
0.04 |
-0.07 |
-0.06 |
-0.11 |
-0.10 |
Increase (Decrease) in Accrued Liabilities |
0.00 |
-0.05 |
-0.06 |
-0.05 |
-0.02 |
Deferred Revenue and Customer Advances and Deposits |
- |
- |
- |
- |
- |
Prepaid Expense and Other Assets |
0.01 |
0.02 |
-0.68 |
-0.66 |
-0.36 |
Other Working Capital |
- |
0.03 |
0.00 |
- |
- |
Other Noncash Items |
- |
- |
- |
- |
- |
Other net |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Operating Activities |
0.00 |
- |
0.00 |
0.00 |
0.52 |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Operating Activities |
-0.07 |
-0.88 |
-1.05 |
-0.91 |
-0.52 |
Capital Expenditures |
- |
- |
- |
- |
- |
Sale of Capital Items |
- |
- |
- |
- |
- |
Short-term Investments Proceeds |
- |
- |
- |
- |
- |
Short-term Investments Acq. |
- |
- |
- |
- |
- |
Real Estate Investments |
- |
- |
- |
- |
- |
Loan Receivable Issued To Vidaplus |
- |
- |
- |
- |
- |
Loan To Other Entity |
- |
- |
- |
- |
- |
Payment For Recovery Of Loan Receivable |
- |
- |
- |
- |
- |
Proceeds From Collection Of Loans Receivable Banco Vida |
- |
- |
- |
- |
- |
Payments To Acquire Loans Receivable |
- |
- |
- |
- |
- |
Restricted Cash and Investments Increase (Decrease) |
- |
- |
- |
- |
- |
Payments to Acquire Loans Receivable |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Deposits |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investments |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank |
- |
- |
- |
- |
- |
Payments to Acquire Businesses, Net of Cash Acquired |
- |
- |
- |
- |
- |
Interest in Subsidiaries and Affiliates |
- |
- |
- |
- |
- |
Sale of businesses |
- |
- |
- |
- |
- |
Accounts payable |
- |
- |
- |
- |
- |
Proceeds from Collection of Loans Receivable |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investing Activities |
- |
- |
- |
- |
- |
Other Net |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Investing Activities |
- |
- |
- |
- |
- |
Short-term debt Net |
- |
- |
- |
- |
- |
Other borrowing transactions |
- |
- |
- |
- |
- |
Long-term debt - borrowings |
- |
- |
- |
- |
- |
Long-term debt - repayments |
- |
- |
- |
- |
- |
Federal Home Loan Bank and Federal Funds |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Comm. Stock |
- |
- |
- |
- |
- |
Partnership and Parent Transactions |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Pref. Stock |
- |
- |
- |
- |
- |
Deposits, Annuities, Contract Holders Funds |
- |
- |
- |
- |
- |
Other financing activities net |
- |
- |
- |
- |
- |
Other net |
- |
- |
- |
- |
- |
Repayments On Loans Payablerelated Party |
- |
- |
- |
- |
- |
Stock Issued During Period Value Issued For Cash |
- |
- |
- |
- |
- |
Operating Cash Flows |
- |
- |
- |
- |
- |
Proceeds From Issuance Of Notes Payable |
- |
- |
- |
- |
- |
Proceeds From Issuance Of Notes Payable |
- |
- |
- |
- |
- |
Payments of Dividends, Preferred Stock and Preference Stock |
- |
- |
- |
- |
- |
Dividends paid |
- |
- |
- |
- |
- |
Net Cash flow from
Financing Activities |
- |
- |
- |
- |
- |
Effect of exchange rate on cash flow |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Free
Cash Flow |
-0.07 |
-0.88 |
-1.05 |
-0.91 |
-0.52 |
Total Cash Flow |
-0.07 |
-0.88 |
-1.05 |
-0.91 |
-0.52 |
Cash & cash equiv. at beg.
of the Year |
11.53 |
12.41 |
12.41 |
12.41 |
12.41 |
Cash & cash equivalents at
end of period |
- |
- |
- |
- |
- |
Cash Interests paid |
- |
- |
- |
- |
- |
Cash Income taxes paid |
- |
- |
-0.66 |
-0.64 |
-0.35 |